Business
Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association’s 84th Scientific Sessions
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its
About this update from Tandem Diabetes Care, Inc.
[{"type":"text","content":" SAN DIEGO--(BUSINESS WIRE)--\nTandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its schedule of presentations for the American Diabetes Association’s (ADA) 84th Scientific Sessions taking place in Orlando, Florida from June 21-24.\n\n\nProduct Theater\n\n\nThe Company will host a Product Theater on Saturday, June 22 from 10:15 am - 11:00 am EDT at Product Theater #1.\n\n\nMeet Tandem Mobi: Tiny pump, big control. The future of Automated Insulin Delivery (AID)\n\n\nPresenters:\n\n\n\nJordan Pinsker, MD, Chief Medical Officer at Tandem Diabetes Care\n\n\n\nHalis Kaan Akturk, MD, Associate Professor of Medicine and Pediatrics at the Barbara Davis Center for Diabetes, University of Colorado\n\n\n\nCari Berget, MPH, RN, CDCES, Director of the PANTHER Program and Research Instructor in Pediatrics at Barbara Davis Center\n\n\n\nDuring this session, new early user insights will be presented on Tandem Mobi, the world’s smallest, durable AID system* that became commercially available in the United States in February of 2024. Presenters will discuss how the unique wearability features of Tandem Mobi combined with the Control-IQ algorithm ushers in a new generation of AID systems. The speakers will also cover the benefits of a small-sized insulin delivery system that allows the ability to disconnect for sports, swimming, and real-life scenarios, and how optimizing algorithm settings can help improve patient outcomes.\n\n\n“This groundbreaking data is the first presentation of Tandem Mobi user insights and demonstrate our continued commitment to advancing diabetes care through innovative technology,” said Dr. Pinsker. “Understanding these early Tandem Mobi insights is critical to help ensure our portfolio of diabetes solutions continues to create a positively different experience for our customers.”\n\n\nPoster Presentations\n\n\nFrom June 22 - June 24, the Company will also release data during the Poster Sessions in the Poster Hall. Tandem authors will be available for questions during the General Poster Sessions scheduled for Saturday, June 22 at 12:30 pm EDT.\n\n\n\nThe t:slim X2 with Control-IQ Technology Overcomes Missed Boluses for Moderate Meals\n\n\n\nTandem Diabetes Care Authors: Larry Fu, Principal Data Scientist; Alex Trahan, Sr. Manager, Data Science; Laurel Me...